Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES              
Net Loss $ (8,984) $ (8,823) $ (6,063) $ (8,005) $ (26,876) $ (21,283)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization         697 747  
Stock-based compensation         6,232 4,463  
Patent write-off         61 47  
Operating lease right-of-use asset amortization         468 447  
Finance lease right-of-use asset amortization     0   11 0  
Changes in assets and liabilities:              
Accounts Receivable         (4,053) (329)  
Prepaid expenses and other current assets         24 (156)  
Other assets         62 (44)  
Accounts payable         464 (107)  
Accrued expenses         (129) (51)  
Accrued salaries and payroll related expenses         468 50  
Operating lease liabilities         (508) (454)  
Deferred revenue         2,663 647  
Net cash used in operating activities         (20,416) (16,023)  
CASH FLOWS FROM INVESTING ACTIVITIES              
Purchase of property and equipment         (553) (451)  
Expenditures for patents         (895) (549)  
Net cash used in investing activities         (1,448) (1,000)  
CASH FLOWS FROM FINANCING ACTIVITIES              
Gross proceeds from sale of common stock         12,303 28,750  
Offering costs in connection with sale of common stock         (403) (2,340)  
Proceeds from exercise of stock options         292 3  
Net cash provided by financing activities         12,192 26,413  
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH         (9,672) 9,390  
CASH, CASH EQUIVALENTS AND RESTRICTED CASH — Beginning of period   $ 25,073   $ 10,838 25,073 10,838 $ 10,838
CASH, CASH EQUIVALENTS AND RESTRICTED CASH — End of period 15,401   20,228   15,401 20,228 25,073
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION              
Taxes Paid         1 1  
SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES              
Common stock issued in settlement of accrued salaries and payroll related expenses         456 363  
Property and equipment included in accounts payable         183 131  
Property and equipment included in accrued expenses         47 239  
Patents included in accounts payable         112 110  
Finance lease included in accounts payable         4 0  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents              
Cash and cash equivalents 15,346       15,346   24,968
Restricted cash 55       55   105
Total cash, cash equivalents and restricted cash $ 15,401   $ 20,228   $ 15,401 $ 20,228 $ 25,073